Contract Pharma: “Akston Biosciences, Seppic Ink Commercial Supply Agreement: Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale”
Opera News: “Sarah Sjostrom, RN, Recognized for Outstanding Commitment at Hebrew SeniorLife’s NewBridge on the Charles Campus”
More Companies to Engage on Twitter in 2009
Hebrew SeniorLife: “Hebrew SeniorLife Raises More than $1.2 Million at 9th Annual EngAGE Proceeds will benefit Hebrew SeniorLife’s health care, communities, research, and teaching that transform the experience of aging”
Birnbach Communications’ Top Predictions for 2013, Part III
Pharmaceutical Technology: “Coronavirus company news summary – US FDA expands Covid-19 booster eligibility to all adults – EMA recommends Lagevrio pill for high risk Covid-19 patients”
Canton Community TV: “In the Spotlight: Dr Pascual-Leone on Alzheimer’s and Dementia: Neurologist Alvaro Pascual-Leone, MD, PhD, Harvard Medical School Professor and Senior Scientist at the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife discusses Alzheimer’s Disease and dementia. Repeats Thursday-Wed.(May 13-19) 8 AM, 2 PM, 8 PM, Midnight”
Birnbach Communications’ Top Predictions for 2013, Part VI
Hopkinton Indepedent on Twitter: “Good morning Hopkinton, here is your daily update. Read about the important role LakePharma may play in the fight against COVID-19 and see which popular town eatery is closing for the winter. Also, see the sign of peace from a Hayden Rowe family and don’t miss tonight’s Open Space Preservation Commission meeting”
Boston Harbor Angels: “AKS-452: The newest vaccine – COVID-19 shot developed by Beverly company reaches trial stage”
Track Record for Predictions for 2013, Part I
eHop: “Hopkinton might end up playing a key role in helping to end the COVID-19 pandemic, as the biotech company LakePharma announced that it will work to develop and produce a vaccine at its facility on South Street”